HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

Benzinga · 3d ago
HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.